A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT01009463 · COMPLETED
Trial details
- NCT number
- NCT01009463
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-25
- Primary completion
- 2011-10-01
- Enrollment
- 1626
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.